1 – 5 of 9
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Molecular and cellular mechanisms of chemoresistance in pancreatic cancer
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Development and In Vitro Characterization of a Gemcitabine-loaded MUC4-targeted Immunoliposome Against Pancreatic Ductal Adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Low MUC4 expression is associated with survival benefit in patients with resectable pancreatic cancer receiving adjuvant gemcitabine
(
- Contribution to journal › Article
-
Mark
Pancreatic Ductal Adenocarcinoma : Current and Evolving Therapies
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Integrin β1, osmosensing, and chemoresistance in mouse ehrlich carcinoma cells
(
- Contribution to journal › Article